These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
9. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study. Hoffmann JJ; Bonnier JJ; de Swart JB; Custers P; Vijgen M Drugs; 1987; 33 Suppl 3():242-6. PubMed ID: 3315602 [TBL] [Abstract][Full Text] [Related]
10. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575 [TBL] [Abstract][Full Text] [Related]
11. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction. Bonnier JJ Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583 [TBL] [Abstract][Full Text] [Related]
12. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Been M; de Bono DP; Muir AL; Boulton FE; Hillis WS; Hornung R Br Heart J; 1985 Mar; 53(3):253-9. PubMed ID: 3882107 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy. Marder VJ; Kinsella PA; Brown MJ Drugs; 1987; 33 Suppl 3():237-41. PubMed ID: 3315601 [TBL] [Abstract][Full Text] [Related]
14. Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States. Anderson JL Drugs; 1987; 33 Suppl 3():154-62. PubMed ID: 3315584 [TBL] [Abstract][Full Text] [Related]
15. Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction. Francis CW; Connaghan DG; Marder VJ Circulation; 1986 Nov; 74(5):1027-36. PubMed ID: 3533310 [TBL] [Abstract][Full Text] [Related]
16. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction. Jackson D Drugs; 1987; 33 Suppl 3():104-11. PubMed ID: 3315574 [TBL] [Abstract][Full Text] [Related]
17. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592 [TBL] [Abstract][Full Text] [Related]
18. Anistreplase: a novel thrombolytic agent for acute myocardial infarction. Marinac JS; North DS; Stringer KA DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460 [TBL] [Abstract][Full Text] [Related]
19. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582 [TBL] [Abstract][Full Text] [Related]
20. [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct]. Doenecke P; Schwerdt H; Hellstern P; Wenzel E; Bette L Klin Wochenschr; 1986 Aug; 64(15):682-7. PubMed ID: 3531704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]